[
    [
        {
            "time": "2023-07-23",
            "original_text": "智通港股研报精读(07.23) | 看好电气设备板块龙头公司、医药板块龙头股和银行板块重点品种",
            "features": {
                "keywords": [
                    "电气设备",
                    "医药板块",
                    "龙头股",
                    "银行板块"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "电气设备",
                    "医药",
                    "银行"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智通港股研报精读(07.23) | 看好电气设备板块龙头公司、医药板块龙头股和银行板块重点品种",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-24",
            "original_text": "上海医药：拟9000万元参与设立生物医药创新转化私募基金",
            "features": {
                "keywords": [
                    "上海医药",
                    "私募基金",
                    "生物医药",
                    "创新科技"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药：拟9000万元参与设立生物医药创新转化私募基金",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-24",
            "original_text": "上海医药：委任梁瑞冰为联席公司秘书",
            "features": {
                "keywords": [
                    "上海医药",
                    "梁瑞冰",
                    "联席公司秘书"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药：委任梁瑞冰为联席公司秘书",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-07-24",
            "original_text": "上海医药(02607)拟出资9000万元参与私募投资基金 实现生物医药领先创新科技及应用更广泛布局",
            "features": {
                "keywords": [
                    "上海医药",
                    "私募投资基金",
                    "生物医药",
                    "创新科技"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药(02607)拟出资9000万元参与私募投资基金 实现生物医药领先创新科技及应用更广泛布局",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-24",
            "original_text": "上海医药(02607.HK)：梁瑞冰获委任为联席公司秘书",
            "features": {
                "keywords": [
                    "上海医药",
                    "梁瑞冰",
                    "联席公司秘书"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药(02607.HK)：梁瑞冰获委任为联席公司秘书",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-07-24",
            "original_text": "上海医药：变更联席公司秘书",
            "features": {
                "keywords": [
                    "上海医药",
                    "联席公司秘书",
                    "变更"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药：变更联席公司秘书",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-07-24",
            "original_text": "上海医药(601607.SH)：拟出资9000万元参设生物医药产业专项基金",
            "features": {
                "keywords": [
                    "上海医药",
                    "生物医药",
                    "产业专项基金"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药(601607.SH)：拟出资9000万元参设生物医药产业专项基金",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-07-24",
            "original_text": "上海医药(601607.SH)拟参设上海上实生物医药创新转化私募投资基金合伙企业",
            "features": {
                "keywords": [
                    "上海医药",
                    "私募投资基金",
                    "生物医药",
                    "创新转化"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药(601607.SH)拟参设上海上实生物医药创新转化私募投资基金合伙企业",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]